2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Revenue | $48M | $19M | $45M | $70M | $80M |
Cost of Revenue | $9M | $298K | $6.2M | $34M | $39M |
Gross Profit | $39M | $19M | $39M | $36M | $41M |
Gross Profit % | 81% | 98% | 86% | 52% | 51% |
R&D Expenses | $0.25 | $2.4 | $0.32 | $0.07 | $0 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Net Income | $36M | -$198M | $34M | $10M | $22M |
Dep. & Amort. | $3.4M | $6.5M | $14M | $7.5M | $5.2M |
Def. Tax | $4.7M | $217M | $4M | $0 | $0 |
Stock Comp. | $2.2M | $3.1M | $1.7M | $3.6M | $2.6M |
Chg. in WC | -$3.2M | -$4.5M | $9.1M | $333K | $5.8M |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Cash | $80M | $29M | $36M | $66M | $83M |
ST Investments | $521M | $2.1M | $0 | $1.5M | $0 |
Cash & ST Inv. | $601M | $31M | $36M | $68M | $83M |
Receivables | $28M | $15M | $25M | $13M | $13M |
Inventory | -$30K | $1 | $18M | $54M | $0 |
Gross revenue nearly doubled year-over-year in Q4 2024, primarily due to the Spanish portfolio sale, which generated €80 million in cash at a 2% premium over book value. Excluding this, gross revenue declined by 4%.
Cash EBITDA increased to €130 million in Q4 2024 from €55 million the previous year, driven by the portfolio sale. Adjusted for this, cash EBITDA declined by 6%.
A significant negative revaluation of €104 million was recorded in Q4 2024 due to challenging macroeconomic conditions, impacting return on equity, which ended at -19% for the year. Excluding the revaluation, ROE was 6%.
The company maintains a strong financial position with an equity ratio of 26% and over €100 million in available liquidity. It plans to focus on deleveraging and refinancing its ACR03 bond maturing in September 2026.
For 2025, Axactor expects lower-end investments within the €100-200 million target range, improved collection performance post-revaluation, and continued growth in its 3PC business segment at healthy margins.